Rang	Name	Position
1	Mr. Jason M. Hollar	CEO & Director
2	Mr. Aaron E. Alt J.D.	Chief Financial Officer
3	Ms. Jessica L. Mayer	Chief Legal & Compliance Officer
4	Mr. Stephen M. Mason	Chief Executive Officer of GMPD segment
5	Ms. Deborah L. Weitzman	Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment
6	Ms. Mary C. Scherer	Senior VP & Chief Accounting Officer
7	Mr. David Frost	Vice President of Investor Relations
8	Ms. Valerie Christine Pitteroff	Chief Human Resources Officer
9	Mr. Craig Cowman	President of Biopharma Solutions & Strategic Sourcing
10	Mr. Ben Brinker	President of Global Operations & Supply Chain

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	12,25%	6,68 Mrd. USD
2	Vanguard Capital Management, LLC	6,57%	3,59 Mrd. USD
3	Wellington Management Company LLP	6,39%	3,49 Mrd. USD
4	Vanguard Portfolio Management, LLC	5,90%	3,22 Mrd. USD
5	State Street Corp	5,19%	2,83 Mrd. USD
6	Geode Capital Management, LLC	2,83%	1,54 Mrd. USD
7	Morgan Stanley - Brokerage Accounts	2,13%	1,16 Mrd. USD
8	FMR Inc	1,82%	1,00 Mrd. USD
9	WCM Investment Management	1,72%	0,94 Mrd. USD
10	NORGES BANK	1,60%	0,87 Mrd. USD
11	Amvescap Plc.	1,51%	0,82 Mrd. USD
12	Bank of America Corp	1,24%	0,68 Mrd. USD
13	Northern Trust Corp	1,20%	0,66 Mrd. USD
14	The Goldman Sachs Group Inc	1,02%	0,56 Mrd. USD
15	UBS Asset Mgmt Americas Inc	1,00%	0,55 Mrd. USD
16	JPMorgan Chase & Co	1,00%	0,54 Mrd. USD
17	Legal & General Group PLC	0,88%	0,48 Mrd. USD
18	Victory Capital Management Inc.	0,85%	0,46 Mrd. USD
19	T. Rowe Price Associates, Inc.	0,80%	0,44 Mrd. USD
20	Acadian Asset Management LLC	0,75%	0,41 Mrd. USD